ARTHROCARE CORP
ARTC
ARTC was delisted on the 29th of May, 2014.
117 hedge funds and large institutions have $1.05B invested in ARTHROCARE CORP in 2013 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 46 increasing their positions, 40 reducing their positions, and 19 closing their positions.
617% more call options, than puts
Call options by funds: $4.87M | Put options by funds: $680K
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
15% more repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 40
14% more capital invested
Capital invested by funds: $917M → $1.05B (+$133M)
1% less funds holding
Funds holding: 118 → 117 (-1)
5% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 19
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VAM
Visium Asset Management
New York
|
+$22.2M |
| 2 |
Westfield Capital Management
Boston,
Massachusetts
|
+$8.91M |
| 3 |
Millennium Management
New York
|
+$7.73M |
| 4 |
Renaissance Technologies
New York
|
+$7.25M |
| 5 |
SCA
SAC Capital Advisors
Stamford,
Connecticut
|
+$6.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$17.2M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
-$12.2M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$11.8M |
| 4 |
WC
Wexford Capital
West Palm Beach,
Florida
|
-$5.49M |
| 5 |
NTC
North Tide Capital
Boston,
Massachusetts
|
-$5.46M |
ARTC Hedge Fund Activity: Q4 2013 in Review
117 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in ARTHROCARE CORP (ARTC) for Q4 2013, worth a combined $1.05B — up 14% from $917M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of ARTC and 18 opened new positions — a net loss of 1 holder — while 40 trimmed existing stakes and 46 added.
The largest buyer was Visium Asset Management, opening a new position worth an estimated $22.2M. The largest seller was BlackRock Advisors, cutting an estimated $17.2M.
- 117 institutional investors held ARTHROCARE CORP (ARTC) as of Q4 2013, down from 118 in Q3 2013.
- Funds reported $1.05B of ARTHROCARE CORP stock for Q4 2013, up 14% quarter-over-quarter.
- 18 funds opened new ARTHROCARE CORP positions in Q4 2013 and 19 closed out, a net change of -1 holder.
- The largest ARTHROCARE CORP buyer in Q4 2013 was Visium Asset Management, an estimated $22.2M added.
- The largest ARTHROCARE CORP seller in Q4 2013 was BlackRock Advisors, an estimated $17.2M sold.
Based on aggregated 13F filings for Q4 2013.